Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 33 (EEF1A1P33)

Target
EEF1A1P33
Molecular classification
Processed pseudogene, Non-coding RNA, Other
01

Overview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 33 (EEF1A1P33) is a processed pseudogene of the EEF1A1 gene, meaning it is a genomic DNA sequence derived from the mRNA of EEF1A1 but is non-functional and does not code a protein. While the parental gene, EEF1A1, encodes an essential translation elongation factor facilitating the delivery of aminoacyl-tRNAs to the ribosome during protein biosynthesis, EEF1A1P33 itself is classified as a non-coding pseudogene and does not exhibit protein-coding function or direct biological activity. The human genome harbors numerous EEF1A1 pseudogenes, most of which lack documented expression, regulatory impact, or disease association. There is no evidence that EEF1A1P33 is a therapeutic target, nor that it interacts with drugs or functions as a biomarker. It is not considered a receptor, enzyme, transporter, or similar pharmacological target. If pseudogene-derived RNAs from EEF1A1P33 exist, their biological significance would be speculative and as yet unreported[2][4][6].

Other names
EEF1A1 pseudogene 33
02

Mechanism of action

None known

03

Biological functions

None established for this pseudogene specifically
04

Disease associations

None established directly for EEF1A1P33

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 33 (EEF1A1P33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 33 (EEF1A1P33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call